CoChat

Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility

Open access
Heikkinen, K, Karppinen, S-M, Soini, Y, Mäkinen, M, Winqvist, R · 2003 · Journal of Medical Genetics
Cited by 107

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Approximately 5–10% of all breast and ovarian cancers are due to genetic predisposition.1 Germline mutations in two major susceptibility genes, BRCA1 and BRCA2 , explain most of the hereditary ovarian cancer cases, but worldwide have been observed only in a fraction of the breast cancer families; in Finland, about 20%.2–4 A small portion of the remaining cases, perhaps 1–2%, appears to be caused by germline mutations in other cancer susceptibility genes such as TP53 , PTEN , AR , and ATM .5 Recently, moderate or low penetrance germline mutations such as 1100delC of CHK2 have also been implicated,6 suggesting that in many cases the phenotypic expression of the disease is accounted for by the combined effect of multiple but more subtle mutations in different target genes.5,7 Despite all these discoveries, many breast cancer families, especially those with fewer than four cases and/or with later disease onset, have cancers due to mutations in still unknown genes. As the protein products of the genes so far indicated are central players in the pathways involved in cell cycle checkpoint functions and in the sensing, transduction, and repair of DNA lesions,5 other similarly acting genes may represent new potential candidates for breast and/or ovarian cancer susceptibility. The Mre11 complex, composed of the proteins MRE11, NBS1, and RAD50, is a vital component in the DNA damage response and is at least partially responsible for connecting DNA damage detection to DNA repair and cell cycle checkpoint functions. The early association of the complex with damaged DNA suggests its involvement in sensing DNA double strand breaks (DSBs). In eukaryotes, DSB repair is handled by two different pathways, homologous recombination (HR) and non-homologous end joining (NHEJ), and the initial step in both is the recognition and signalling of the damage …

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jmg.40.12.e131

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 107

Metadata

Authors
Heikkinen, K., Karppinen, S.-M., Soini, Y., Mäkinen, M., & Winqvist, R.
Venue
Journal of Medical Genetics
Publisher
BMJ
Published
2003-12
Volume
40
Issue
12
Pages
e131-e131
ISSN
  • 0022-2593 (ISSN-L)
  • 1468-6244
OpenAlex
W2166752171
Cited by
107
References
13
FWCI
1.17
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility. https://app.cochat.ai/papers/10.1136/jmg.40.12.e131
The paper
Heikkinen, K., Karppinen, S.-M., Soini, Y., Mäkinen, M., & Winqvist, R. (2003). Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility. Journal of Medical Genetics. https://doi.org/10.1136/jmg.40.12.e131

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.